|
A prospective phase 2/3 multicenter study of 18F-DCFPyL PET/CT imaging in patients with prostate cancer: Examination of diagnostic accuracy (OSPREY). |
| |
|
Consulting or Advisory Role - Advanced Accelerator Applications; Astellas Pharma; Bayer; Blue Earth Diagnostics; Endocyte; Tokai Pharmaceuticals; Tolmar |
Research Funding - Bayer (Inst); Corcept Therapeutics (Inst); Endocyte (Inst); Progenics (Inst); Roche/Genentech (Inst); Sanofi (Inst) |
Travel, Accommodations, Expenses - Bayer; Endocyte |
| |
|
Research Funding - Progenics (Inst) |
| |
|
Stock and Other Ownership Interests - Johnson & Johnson; Pfizer |
|
Consulting or Advisory Role - Hybridyne Imaging Technologies |
|
Research Funding - Bayer; Progenics (Inst) |
Travel, Accommodations, Expenses - Bayer |
| |
|
No Relationships to Disclose |
| |
|
Research Funding - Progenics (Inst) |
| |
|
|
Consulting or Advisory Role - Blue Earth Diagnostics; BTG; GE Healthcare; GlaxoSmithKline |
Research Funding - Blue Earth Diagnostics; Progenics |
Travel, Accommodations, Expenses - Siemens (I) |
| |
|
Consulting or Advisory Role - AstraZeneca; Eisai; Roche |
Speakers' Bureau - AstraZeneca |
Research Funding - Acerta Pharma (Inst); ARIAD (Inst); AstraZeneca (Inst); Bayer (Inst); BIND Biosciences (Inst); BIND Biosciences (Inst); Bristol-Myers Squibb (Inst); Covance (Inst); Genentech (Inst); Hoosier Cancer Research Network (Inst); Merck Sharp & Dohme (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Pfizer (Inst); Prometheus (Inst); Roche (Inst); United Biosource Corporation (Inst) |
| |
|
No Relationships to Disclose |
| |
|
Research Funding - Progenics (Inst) |
| |
|
Consulting or Advisory Role - Progenics |
| |
|
Stock and Other Ownership Interests - Adient Medical |
Consulting or Advisory Role - Adient Medical |
Patents, Royalties, Other Intellectual Property - Patent disclosures, provisionals submitted for instrument to analyze biopsy specimens (unrelated to the small renal masses topic). Patent holder for device related to x-ray imaging data collection (unrelated to small renal masses topic)....July 2008. |
Other Relationship - Society of Interventional Radiology Foundation |
| |
|
|
Stock and Other Ownership Interests - Progenics |
| |
|
|
Stock and Other Ownership Interests - Progenics |
| |
|
No Relationships to Disclose |
| |
|
|
Stock and Other Ownership Interests - Progenics |
| |
|
No Relationships to Disclose |
| |
|
|
|
| |
|
|
|
Stock and Other Ownership Interests - Progenics |
| |
|
|
Honoraria - Johnson & Johnson |
Research Funding - Celsee Diagnostics; Johnson & Johnson (Inst) |